Brief: Panbela Announces Partial Clinical Hold Lifted On Phase I Polyamine Metabolic Inhibitor Study In Pancreatic Cancer
15/04/2021 13:17
April 15 (Reuters) - Panbela Therapeutics Inc PBLA.O :
* PANBELA ANNOUNCES PARTIAL CLINICAL HOLD LIFTED ON PHASE I
POLYAMINE METABOLIC INHIBITOR STUDY IN PANCREATIC CANCER
* PANBELA THERAPEUTICS INC - IN FUTURE DOSE-FINDING STUDIES
SCREENING FOR RETINAL TOXICITY WILL BE INCLUDED
Source text for Eikon: ID:nGNX17gscg
Further company coverage: PBLA.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Panbela Therapeutics
See all newsBrief: Panbela Therapeutics Announces Third Independent Safety Review Of Phase 3 Aspire Clinical Trial DSMB Recommended Continuation With No Trial Modification
Brief: Nasdaq Notifies Panbela Therapeutics Notice Of Delisting Or Failure To Satisfy A Continued Listing Rule Or Standard
Brief: Panbela Announces Pricing of Approximately $9 Mln Public Offering
U.S. STOCKS ON THE MOVE-Fisker, Best Buy, NuStar Energy
Brief: Panbela Therapeutics Announces Exercise Of Warrants And Issuance Of New Warrants